Dual Medical Therapy for Treatment of Arrhythmias in Cardiac Sarcoidosis.

ABSTRACT: Anti-arrhythmics can be useful for ventricular arrhythmias in cardiac sarcoidosis (CS) that are refractory to immunosuppression. However, there is conflicting evidence on the efficacy of immunosuppression for treating arrhythmias in CS patients and a lack of data to support using immunosuppression alone as an initial strategy. The objective of this study was to assess for differences in arrhythmia burden over time with currently used immunosuppression and anti-arrhythmic regimens. Patients with CS and implanted cardiac devices were identified from a single-center registry. Study participants were retrospectively classified based on the medication regimen as follows: control (no therapy), immunosuppression, anti-arrhythmics, or dual therapy. Device interrogations were reviewed for premature

SUBMITTER: Sibilia R 

PROVIDER: S-EPMC9721303 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature